{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "August 2019, 56-year-old male with occasional smoking history presented with cough and sputum for 2 weeks, and shortness of breath for 4 days.",
        "clinical_data": {
          "HPI": [
            {
              "summary": "56-year-old male presented with cough and sputum for 2 weeks, and shortness of breath for 4 days.",
              "duration": "2 weeks",
              "onset": "August 2019",
              "associated_symptoms": [
                "C0010200",
                "C0038990"
              ]
            }
          ],
          "social_history": [
            {
              "category": "smoking",
              "status": "past",
              "description": "occasional smoking history"
            }
          ]
        }
      }
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "Contrast-enhanced CT scan showed a 8.0 cm \u00d7 6.9 cm mass in the lower lobe of right lung, with multiple bilateral pulmonary nodules, hilum of right lung and mediastinal lymph node metastasis, and right sided pleural effusion.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Mass",
              "body_part": "Lower lobe of right lung",
              "modality": "CT",
              "finding": "8.0 cm \u00d7 6.9 cm mass",
              "impression": "Mass in the lower lobe of right lung, with multiple bilateral pulmonary nodules, hilum of right lung and mediastinal lymph node metastasis, and right sided pleural effusion",
              "date": null
            },
            {
              "type": "Pulmonary nodule",
              "body_part": "Lung",
              "modality": "CT",
              "finding": "Multiple bilateral pulmonary nodules",
              "impression": "Mass in the lower lobe of right lung, with multiple bilateral pulmonary nodules, hilum of right lung and mediastinal lymph node metastasis, and right sided pleural effusion",
              "date": null
            },
            {
              "type": "Lymph node metastasis",
              "body_part": "Hilum of right lung",
              "modality": "CT",
              "finding": "Hilum of right lung and mediastinal lymph node metastasis",
              "impression": "Mass in the lower lobe of right lung, with multiple bilateral pulmonary nodules, hilum of right lung and mediastinal lymph node metastasis, and right sided pleural effusion",
              "date": null
            },
            {
              "type": "Lymph node metastasis",
              "body_part": "Mediastinum",
              "modality": "CT",
              "finding": "Hilum of right lung and mediastinal lymph node metastasis",
              "impression": "Mass in the lower lobe of right lung, with multiple bilateral pulmonary nodules, hilum of right lung and mediastinal lymph node metastasis, and right sided pleural effusion",
              "date": null
            },
            {
              "type": "Pleural effusion",
              "body_part": "Right sided pleura",
              "modality": "CT",
              "finding": "Right sided pleural effusion",
              "impression": "Mass in the lower lobe of right lung, with multiple bilateral pulmonary nodules, hilum of right lung and mediastinal lymph node metastasis, and right sided pleural effusion",
              "date": null
            }
          ]
        }
      }
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "Right lung biopsy showed invasive lung adenocarcinoma. EGFR mutation and ALK tests showed negative results.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Biopsy",
              "body_part": "Right lung",
              "modality": "other",
              "finding": "invasive lung adenocarcinoma"
            }
          ],
          "diagnoses": [
            {
              "code": "C0242397",
              "label": "Adenocarcinoma of lung",
              "status": "active"
            }
          ]
        }
      }
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "PD-L1 expression was negative after immunohistochemical (IHC) assay. Diagnosed with right lung adenocarcinoma (T4N2M1a, stage \u2163), with an Eastern Cooperative Oncology Group performance status of 1. Baseline chest CT showing a lung mass in the right lower lobe.",
        "clinical_data": {
          "labs": [
            {
              "test": "PD-L1 expression",
              "value": "negative",
              "unit": null,
              "flag": "abnormal"
            }
          ],
          "diagnoses": [
            {
              "code": "C34.9",
              "label": "lung adenocarcinoma",
              "status": "active",
              "onset_date": null
            }
          ],
          "imaging": [
            {
              "type": "Chest CT",
              "body_part": "lung",
              "modality": "CT",
              "finding": "lung mass in the right lower lobe",
              "impression": null,
              "date": null
            }
          ],
          "functional_status": [
            {
              "domain": "general",
              "description": "Eastern Cooperative Oncology Group performance status of 1",
              "score": "1",
              "scale": "Eastern Cooperative Oncology Group"
            }
          ]
        }
      }
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "Patient started first-line pemetrexed (850mg) plus nidaplatin (140\u2009mg) after diagnosis. Received 6 cycles of platinum-based doublets and 1 cycle of pemetrexed disodium maintenance therapy and experienced disease progression (PD), with a progression-free survival (PFS) of 5 months.",
        "clinical_data": {
          "medications": [
            {
              "drug": "pemetrexed",
              "dosage": "850mg",
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "nidaplatin",
              "dosage": "140 mg",
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "pemetrexed disodium",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ],
          "diagnoses": [
            {
              "code": null,
              "label": "disease progression",
              "status": "active",
              "onset_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "Second-line therapy: nivolumab (200\u2009mg, PFS, 2 months). Chest CT before second-line nivolumab.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C1873352",
              "dosage": "200 mg",
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ],
          "imaging": [
            {
              "type": "C0008935",
              "body_part": "C0008043",
              "modality": "CT",
              "finding": null,
              "impression": null,
              "date": null
            }
          ]
        }
      }
    },
    {
      "id": "N7",
      "label": "Step 7",
      "customData": {
        "node_id": "G",
        "node_step_index": 6,
        "content": "Third-line therapy: nanoparticle albumin bound paclitaxel (450mg) plus anlotinib (12mg daily, PFS, 11.5 months). Chest CT at disease progression.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0889308",
              "dosage": "450mg",
              "frequency": null,
              "modality": "IV",
              "start_date": null,
              "end_date": null,
              "indication": "C0018799"
            },
            {
              "drug": "C4042526",
              "dosage": "12mg",
              "frequency": "daily",
              "modality": "oral",
              "start_date": null,
              "end_date": null,
              "indication": "C0018799"
            }
          ],
          "imaging": [
            {
              "type": "C0008794",
              "body_part": "C0008043",
              "modality": "CT",
              "finding": "disease progression",
              "impression": null,
              "date": null
            }
          ]
        }
      }
    },
    {
      "id": "N8",
      "label": "Step 8",
      "customData": {
        "node_id": "H",
        "node_step_index": 7,
        "content": "Partial response at 4 months after third-line therapy.",
        "clinical_data": {}
      }
    },
    {
      "id": "N9",
      "label": "Step 9",
      "customData": {
        "node_id": "I",
        "node_step_index": 8,
        "content": "April 2021, patient began to have headaches and dizziness. Baseline chest CT and brain MRI before crizotinib.",
        "clinical_data": {
          "HPI": [
            {
              "summary": "Patient began to have headaches and dizziness in April 2021.",
              "onset": "2021-04",
              "associated_symptoms": [
                "headaches",
                "dizziness"
              ]
            }
          ],
          "imaging": [
            {
              "type": "Chest CT",
              "body_part": "chest",
              "modality": "CT",
              "date": "2021-04"
            },
            {
              "type": "Brain MRI",
              "body_part": "brain",
              "modality": "MRI",
              "date": "2021-04"
            }
          ],
          "medications": [
            {
              "drug": "crizotinib",
              "start_date": "2021-04"
            }
          ]
        }
      }
    },
    {
      "id": "N10",
      "label": "Step 10",
      "customData": {
        "node_id": "J",
        "node_step_index": 9,
        "content": "Brain magnetic resonance imaging showed multiple brain metastases. Partial response of all lung lesions and brain lesions after 2 months of crizotinib, but new liver lesions.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Brain magnetic resonance imaging",
              "body_part": "Brain",
              "modality": "MRI",
              "finding": "multiple brain metastases"
            }
          ],
          "medications": [
            {
              "drug": "Crizotinib",
              "start_date": "None",
              "end_date": "None"
            }
          ],
          "diagnoses": [
            {
              "code": "C0242964",
              "label": "Lung cancer",
              "status": "active"
            },
            {
              "code": "C0027651",
              "label": "Metastasis",
              "status": "active"
            }
          ]
        }
      }
    },
    {
      "id": "N11",
      "label": "Step 11",
      "customData": {
        "node_id": "K",
        "node_step_index": 10,
        "content": "Chest CT and brain MRI before entrectinib showing partial response and brain lesions progression.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Computed tomography",
              "body_part": "Chest",
              "modality": "CT",
              "finding": "partial response"
            },
            {
              "type": "Magnetic resonance imaging",
              "body_part": "Brain",
              "modality": "MRI",
              "finding": "brain lesions progression"
            }
          ],
          "medications": [
            {
              "drug": "Entrectinib"
            }
          ]
        }
      }
    },
    {
      "id": "N12",
      "label": "Step 12",
      "customData": {
        "node_id": "L",
        "node_step_index": 11,
        "content": "CT showed a partial response of the lung after 3 months.",
        "clinical_data": {
          "imaging": [
            {
              "type": "CT scan",
              "body_part": "lung",
              "modality": "CT",
              "finding": "partial response",
              "date": null
            }
          ]
        }
      }
    },
    {
      "id": "N13",
      "label": "Step 13",
      "customData": {
        "node_id": "M",
        "node_step_index": 17,
        "content": "Biopsy from neck lymph node showed metastasis from lung cancer. Next-generation sequencing (NGS) of the biopsy identified EZR-ROS1(E9: R33) (1.25% abundance). IHC showed positive expression of PD-L1, with tumor cell proportion score equal to 20% (SP263 antibody).",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C34",
              "label": "Lung Cancer",
              "status": "active"
            },
            {
              "code": "C0206139",
              "label": "Metastasis",
              "status": "active"
            }
          ],
          "labs": [
            {
              "test": "Next-generation sequencing",
              "value": "EZR-ROS1(E9: R33) (1.25% abundance)",
              "unit": "%",
              "flag": "abnormal"
            },
            {
              "test": "PD-L1 expression",
              "value": "20",
              "unit": "%",
              "flag": "abnormal"
            }
          ],
          "procedures": [
            {
              "name": "Biopsy",
              "location": "Neck Lymph Node"
            }
          ]
        }
      }
    },
    {
      "id": "N14",
      "label": "Step 14",
      "customData": {
        "node_id": "N",
        "node_step_index": 18,
        "content": "April 23, 2021, the patient received crizotinib",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0974735",
              "start_date": "2021-04-23"
            }
          ]
        }
      }
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Patient's cough, sputum, and shortness of breath led to a contrast-enhanced CT scan."
      }
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "CT scan findings prompted a right lung biopsy.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [],
          "change_type": "addition",
          "target_domain": "procedure"
        }
      }
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "Biopsy results and PD-L1 testing led to a diagnosis and staging.",
        "transition_event": {
          "trigger_type": "lab_change",
          "trigger_entities": [],
          "change_type": "addition",
          "target_domain": "diagnosis"
        }
      }
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "Diagnosis of lung adenocarcinoma led to the initiation of first-line chemotherapy with pemetrexed and nidaplatin.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0025598",
            "C0011581"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "Disease progression after first-line therapy prompted a switch to second-line therapy with nivolumab.",
        "transition_event": {
          "trigger_type": "interpretation",
          "trigger_entities": [],
          "change_type": "progression",
          "target_domain": "diagnosis"
        }
      }
    },
    {
      "from": "N6",
      "to": "N7",
      "data": {
        "edge_id": "F_to_G",
        "branch_flag": true,
        "content": "Nivolumab was given as a second-line therapy, but the patient progressed after 2 months. Third-line therapy was then started.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N7",
      "to": "N8",
      "data": {
        "edge_id": "G_to_H",
        "branch_flag": true,
        "content": "Patient had a partial response at 4 months after third-line therapy."
      }
    },
    {
      "from": "N8",
      "to": "N9",
      "data": {
        "edge_id": "H_to_I",
        "branch_flag": true,
        "content": "New symptoms of headaches and dizziness prompted further imaging.",
        "transition_event": {
          "trigger_type": "symptom_onset",
          "trigger_entities": [
            "C0018681",
            "C0012539"
          ],
          "change_type": "addition",
          "target_domain": "symptom",
          "timestamp": "2021-04"
        }
      }
    },
    {
      "from": "N9",
      "to": "N10",
      "data": {
        "edge_id": "I_to_J",
        "branch_flag": true,
        "content": "Headaches and dizziness led to brain MRI, revealing multiple brain metastases.",
        "transition_event": {
          "trigger_type": "imaging",
          "trigger_entities": [],
          "change_type": "progression",
          "target_domain": "imaging"
        }
      }
    },
    {
      "from": "N10",
      "to": "N11",
      "data": {
        "edge_id": "J_to_K",
        "branch_flag": true,
        "content": "Partial response of lung and brain lesions, but new liver lesions, led to consideration of entrectinib.",
        "transition_event": {
          "trigger_type": "interpretation",
          "trigger_entities": [],
          "change_type": ""
        }
      }
    }
  ]
}